These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 31586192)
1. The anticipated revision of the grading criteria for adult isocitrate dehydrogenase-mutant diffuse glioma within the neuro-oncology community. Komori T Neuro Oncol; 2019 Dec; 21(12):1485-1486. PubMed ID: 31586192 [No Abstract] [Full Text] [Related]
2. Updating the grading criteria for adult diffuse gliomas: beyond the WHO2016CNS classification. Komori T Brain Tumor Pathol; 2020 Jan; 37(1):1-4. PubMed ID: 32060660 [No Abstract] [Full Text] [Related]
3. Mitotic index is (still) important for grading isocitrate dehydrogenase (IDH)-mutant astrocytoma. Roberts KF; Dahiya SM Neuro Oncol; 2023 Aug; 25(8):1450-1451. PubMed ID: 37097042 [No Abstract] [Full Text] [Related]
4. Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas. Akyerli CB; Yüksel Ş; Can Ö; Erson-Omay EZ; Oktay Y; Coşgun E; Ülgen E; Erdemgil Y; Sav A; von Deimling A; Günel M; Yakıcıer MC; Pamir MN; Özduman K J Neurosurg; 2018 Apr; 128(4):1102-1114. PubMed ID: 28621624 [TBL] [Abstract][Full Text] [Related]
5. [IDH mutation on glioma]. Mukasa A Gan To Kagaku Ryoho; 2011 Jun; 38(6):937-40. PubMed ID: 21751529 [No Abstract] [Full Text] [Related]